A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
- Status
- RECRUITING
- Phase
- N/A
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
- Status
- COMPLETED
- Phase
- PHASE2
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Dose Finding Study of VN-0200
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2
Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke
- Status
- UNKNOWN
- Phase
- N/A
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE4
A Study of DS-9606a in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comprehensive Outcomes for After Cancer Health
- Status
- RECRUITING
- Phase
- NA
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status
- Status
- COMPLETED
- Phase
- N/A